AdaptHealth Corp. Q2 2026 Earnings Recap

AHCO Q2 2026 August 6, 2026

Get alerts when AHCO reports next quarter

AdaptHealth's shares plunged 40% following a disappointing outlook driven by significant margin compression and operational challenges related to its West Coast capitated contract, which is weighing heavily on near-term profitability.

Earnings Per Share Miss

$0.06 vs $0.17 est.

-64.5% surprise

Revenue Miss

740307000 vs 846774400 est.

-12.6% surprise

Market Reaction

1-Day -5.87%

See AHCO alongside your other holdings

Add to your portfolio — free

Key Takeaways

Q2 net revenue from continuing operations grew 12.7% YoY to $740.3 million, driven by 15.9% organic growth.
West Coast capitated contract added 10.7 points to organic growth but resulted in elevated costs and inefficiencies.
Adjusted EBITDA margin contracted to 17.8%, impacted by $40 million in expected profitability headwinds from the West Coast contract.
Elevated sleep resupply and enteral volumes created transitory and structural cost pressures.
Management is implementing operational fixes including workflow alignment, technology adoption, and delivery model changes to stabilize margins.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit AHCO on AllInvestView.